CPT code 0781T represents a bronchoscopic, catheter-based circumferential radiofrequency ablation performed in the main bronchus of each lung to destroy pulmonary nerves. As an emerging bronchoscopic therapeutic intervention, this procedure is relevant nationally for pulmonology, interventional pulmonology, and thoracic surgery practices exploring minimally invasive options for airway-targeted neuromodulation.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise policy and coverage context, payer-specific considerations, and benchmarking where available. The publication summarizes clinical context for the procedure, typical sites of service (hospital outpatient departments and ambulatory surgical centers), common billing modifiers used with complex procedures, and gaps in standardized coding and diagnosis mapping.

This resource provides clinicians, billing teams, and policy analysts with an overview of what CPT code 0781T denotes, how it is commonly billed, and the types of documentation and service settings associated with the procedure. Data not available in the input is noted where relevant, and the report focuses on national-level implications rather than state-specific guidance.